AIs block the conversion of androstenedione into estrogen and are found to be more effective than tamoxifen in treating post menopausal women with ER+ breast cancers.90–92 Though, lot of cytotoxic drugs is available, but still challenges in treatment remains. Here, ESR1 is linked to breast cancer.